Christina H Ruhlmann

About

Christina H Ruhlmann is an Associate Professor at the University of Southern Denmark. Her research primarily focuses on patient education, treatment outcomes of immune checkpoint inhibitors, and the management of chemotherapy-induced side effects. Recent articles explore key areas such as the efficacy of treatments for melanoma, the impact of patient characteristics on treatment outcomes, and the identification of immune-related adverse events. She contributes to the development of consensus recommendations in oncology care within Denmark.